Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Caroppo

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 10, 2025
Biconcave vertebral fractures as a possible distinctive feature of indolent systemic mastocytosis compared with primary osteoporosisGaetano Paride Arcidiacono, Marco Onofrio Torres, Francesca Zanchetta, et al.
Italian Journal of Dermatology and Venereology|April 23, 2024
The new Italian SIDAPA Baseline Series for patch testing (2023): an update according to the new regulatory pathway for contact allergensLuca Stingeni, Leonardo Bianchi, Elena S Caroppo, et al.
Clinical and Experimental Dermatology|February 3, 2025
Efficacy and Drug Survival of Tralokinumab in Severe Atopic Dermatitis: An 18-Month Multicenter ExperienceFrancesca Barei, Paolo Calzari, Elena Pezzolo, et al.
Italian Journal of Pediatrics|June 14, 2022
Narrative review on the management of moderate-severe atopic dermatitis in pediatric age of the Italian Society of Pediatric Allergology and Immunology (SIAIP), of the Italian Society of Pediatric Dermatology (SIDerP) and of the Italian Society of Pediatrics (SIP)Elena Galli, Anna Belloni Fortina, Giampaolo Ricci, et al.
Journal of Clinical Medicine|March 27, 2025
Effectiveness of Tralokinumab Across Atopic Dermatitis PhenotypesFrancesca Barei, Paolo Calzari, Elena Pezzolo, et al.
Future Oncology (London, England)|September 13, 2018
The Italian Mastocytosis Registry: 6-year experience from a hospital-based registrySerena Merante, Virginia V Ferretti, Chiara Elena, et al.
The Journal of Investigative Dermatology|February 13, 2021
Clinical Impact of Skin Lesions in Mastocytosis: A Multicenter Study of the European Competence Network on MastocytosisElisabeth Aberer, Wolfgang R Sperr, Agnes Bretterklieber, et al.
Allergy|February 29, 2020
Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classificationJakub Trizuljak, Wolfgang R Sperr, Lucie Nekvindová, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 21, 2020
Scoring the Risk of Having Systemic Mastocytosis in Adult Patients with Mastocytosis in the SkinDavid Fuchs, Alex Kilbertus, Karin Kofler, et al.
The Lancet. Haematology|November 3, 2019
International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort studyWolfgang R Sperr, Michael Kundi, Ivan Alvarez-Twose, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 10, 2025
Biconcave vertebral fractures as a possible distinctive feature of indolent systemic mastocytosis compared with primary osteoporosisGaetano Paride Arcidiacono, Marco Onofrio Torres, Francesca Zanchetta, et al.
Italian Journal of Dermatology and Venereology|April 23, 2024
The new Italian SIDAPA Baseline Series for patch testing (2023): an update according to the new regulatory pathway for contact allergensLuca Stingeni, Leonardo Bianchi, Elena S Caroppo, et al.
Clinical and Experimental Dermatology|February 3, 2025
Efficacy and Drug Survival of Tralokinumab in Severe Atopic Dermatitis: An 18-Month Multicenter ExperienceFrancesca Barei, Paolo Calzari, Elena Pezzolo, et al.
Italian Journal of Pediatrics|June 14, 2022
Narrative review on the management of moderate-severe atopic dermatitis in pediatric age of the Italian Society of Pediatric Allergology and Immunology (SIAIP), of the Italian Society of Pediatric Dermatology (SIDerP) and of the Italian Society of Pediatrics (SIP)Elena Galli, Anna Belloni Fortina, Giampaolo Ricci, et al.
Journal of Clinical Medicine|March 27, 2025
Effectiveness of Tralokinumab Across Atopic Dermatitis PhenotypesFrancesca Barei, Paolo Calzari, Elena Pezzolo, et al.
Future Oncology (London, England)|September 13, 2018
The Italian Mastocytosis Registry: 6-year experience from a hospital-based registrySerena Merante, Virginia V Ferretti, Chiara Elena, et al.
The Journal of Investigative Dermatology|February 13, 2021
Clinical Impact of Skin Lesions in Mastocytosis: A Multicenter Study of the European Competence Network on MastocytosisElisabeth Aberer, Wolfgang R Sperr, Agnes Bretterklieber, et al.
Allergy|February 29, 2020
Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classificationJakub Trizuljak, Wolfgang R Sperr, Lucie Nekvindová, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 21, 2020
Scoring the Risk of Having Systemic Mastocytosis in Adult Patients with Mastocytosis in the SkinDavid Fuchs, Alex Kilbertus, Karin Kofler, et al.
The Lancet. Haematology|November 3, 2019
International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort studyWolfgang R Sperr, Michael Kundi, Ivan Alvarez-Twose, et al.
Pageof 6